Meeting NewsVideo

VIDEO: Efgartigimod safe, effective in primary immune thrombocytopenia

December 23, 2019
ORLANDO — A 3-week treatment cycle of efgartigimod, a neonatal Fc receptor antagonist, was well tolerated and effective in patients with…
Meeting News

Hemophilia A patients ‘highly satisfied’ after switching to emicizumab

December 23, 2019
ORLANDO — Patients with hemophilia A who had higher annual bleeding rates and poor adherence to infusion-based prophylaxis were more likely to…
Meeting NewsVideo

VIDEO: Apixaban demonstrates benefit over other anticoagulation treatments

December 20, 2019
ORLANDO — Apixaban reduced the risk for recurrent venous thromboembolism compared with low-molecular-weight heparin and warfarin, according to…
Meeting NewsVideo

VIDEO: Aspirin linked to bleeding events in patients receiving direct oral anticoagulants

December 20, 2019
ORLANDO — In this video at the ASH Annual Meeting and Exposition, Thein H. Oo, MD, FRCPE, FACP, reviews a study that showed the addition of…
Meeting NewsVideo

VIDEO: Crizanlizumab may reduce hospitalization in sickle cell disease

December 19, 2019
ORLANDO — Julie Kanter, MD, from the division of hematology-oncology at the University of Alabama-Birmingham, discussed the first-ever…
Meeting NewsVideo

VIDEO: Serum protein changes indicate response to siltuximab in Castleman disease

December 16, 2019
ORLANDO — Researchers identified proteins that began to change within 8 days of initiating siltuximab in patients with idiopathic multicentric…
Meeting NewsVideo

VIDEO: Gene therapy shows promise in severe hemophilia A

December 16, 2019
ORLANDO — SB-525 gene therapy resulted in dose-dependent and sustained increases in Factor VIII levels in adult patients with severe hemophilia…
Meeting NewsVideo

VIDEO: ASH recognizes research on molecular mechanisms of blood coagulation

December 12, 2019
ORLANDO — In this video at the ASH Annual Meeting and Exposition, Sriram M. Krishnaswamy, PhD, of the University of Pennsylvania and…
Meeting NewsVideo

VIDEO: Practicing hematologists should prepare for paradigm shift in treatment

December 11, 2019
ORLANDO, Fla. — In this video at the ASH Annual Meeting and Exposition, Steven W. Pipe, MD, professor of pediatrics and pathology at the…
Meeting News

Hemophilia B clinically less severe than A, though with similar QOL

December 10, 2019
ORLANDO – Despite clinical evidence that hemophilia B presents with less severity on a clinical level than hemophilia A, patients report…